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The heat-stable antigen, CD24, is a cell-surface
sialoglycoprotein expressed on immature cells that
disappears after they have reached their final stage of
differentiation. In mice, CD24 expression is preferentially
upregulated in the developing mouse metanephros as
compared with the surrounding intermediate mesoderm, but
its role and expression in the developing human kidney has
not been well described. Here we found in normal human
fetal kidneys (8 to 38 weeks of gestation) that CD24
expression was upregulated and restricted to the early
epithelial aggregates of the metanephric blastema and to the
committed proliferating tubular epithelia of the S-shape
bodies. Individual cells expressing CD24 were identified in
the interstitium of later gestation and postnatal kidneys. In
freshly isolated cells, FACS analysis identified distinct CD24þ
and CD24þ133þ cell populations constituting up to 16 and
14 percent, respectively, of the total cells analyzed. Early fetal
urinary tract obstruction resulted in upregulation of CD24
expression both in developing epithelial structures of early
stages and in the cells of the injured tubular epithelium of
the later gestation kidneys. Our results highlight the cell-
specific expression of CD24 in the developing human kidney
and its dysregulation during fetal urinary tract obstruction.
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Novel approaches for regenerative medicine include the use
of stem and progenitor cell therapy, which may be useful for
repair of kidneys damaged by disease.1 Uninduced meta-
nephric mesenchymal cells isolated from embryonic kidneys
have been shown to form renal epithelial structures, and also
integrate into the developing renal collecting system of the
embryo.2,3 Using early fetal mouse metanephric tissue and a
subtractive gene array strategy, Challen et al.4 defined a
number of genes that were preferentially upregulated in the
developing mouse metanephros when compared with the
surrounding intermediate mesoderm. Among these, CD24
and cadherin-11, both cell-surface proteins, were significantly
upregulated. Recent studies have also identified a population
of parietal epithelial cells, isolated from the Bowman’s capsule
of human adult kidneys, which are CD24þCD133þ , and
which show properties of self-renewal, pluripotency, and the
ability to engraft in injured mouse kidneys.5,6 This same
group characterized a CD24þCD133þ renal progenitor cell
population in human embryonic kidneys with a similar
ability of self-renewal, pluripotency, and engraftment in
injured kidneys.7
In this study, we have shown the temporal and spatial
expression of CD24 during normal human fetal kidney
development and in kidneys affected by fetal urinary tract
obstruction.
RESULTS
Ontogeny of CD24 expression
CD24 protein expression was analyzed by immunohistochem-
istry. Expression was noted as early as 8 weeks gestation and
was localized specifically and abundantly in early induced
epithelial cells in the nephrogenic zone of the developing
metanephros (Figure 1). Under high-power magnification,
there was abundant expression in the early-induced epithelial
aggregates, derived from the metanephric blastema cells, most
pronounced in the vesicle and comma-shaped stage of
epithelial differentiation, persisting into the S-shape nephron
(Figure 1, insets; Figures 2a–c). These features were most
apparent in the earlier gestation kidneys (Figure 2).
The subcellular distribution of CD24 changed with
increasing gestational age. In fetal kidneys at 8 and 11 weeks
gestation, CD24 immunoreactivity localized to the apical and
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basolateral membranes (Figure 1, insets; Figure 2a), at 17
weeks gestation was localized more diffusely to the cytoplasm
(Figure 2b), and by 27 weeks was in the cytoplasm of the
epithelia of the developing S-shape nephrons and in scattered
interstitial cells (Figure 2c). Very weak CD24 immunoreac-
tivity was detected in the occasional comma and S-shape
bodies in the nephrogenic zone of 36-week gestation kidneys
(Figure 2d). After nephrogenesis was complete, CD24
expression was absent in most epithelia of the nephron
(Figure 2e) but again was found in scattered interstitial cells
(Figure 2f). In the postnatal kidneys CD24 showed punctate
expression in the cells of the macula densa, adjacent to the
juxtaglomerular cells of the glomerular vasculature (Figures
2g and h).
Ontogeny of CD133 expression
In the 11-week gestation kidneys, CD133 immunoreactivity
colocalized with CD24 in the epithelia of the developing
ureteric bud, renal vesicles, and S-shape bodies (Figure 2a).
However, in contrast to CD24 expression, CD133 localized to
the apical membrane throughout the developing ureteric bud
epithelium (Figure 2a), and was observed in the cells of the
uninduced metanephric mesenchyme. At this stage cells
showed uniform surface membrane expression of the CD133
protein. The later gestation 17- to 27-week kidneys showed
similar CD133 expression; however uninduced metanephric
mesenchyme contained significantly less cells expressing
CD133 (Figures 2b and c). After completion of nephrogen-
esis, and with development of vascularized glomeruli, CD133
CD24 8 weeks
Figure 1 | Fetal kidney CD24 expression. Eight week gestation
human fetal kidney with CD24 immunoreactivity (IR) (red)
localized to early-induced epithelial cells in the nephrogenic zone
(arrows). Bar¼ 100 mm. There was abundant expression in the
early-induced epithelial aggregates (insets). Bars¼ 10mm.
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Figure 2 |Ontogeny of CD24 and CD133 expression. (a–c)
Eleven, 17, and 27 week gestation kidneys respectively, showing
CD24-IR in the early epithelial aggregate (a), vesicle (v), and
comma-shaped (c) stage of epithelial differentiation, persisting
into the S-shape nephron (s) (arrows). CD133-IR (green) was
colocalized to epithelial precursors of the developing tubular
epithelium and to the apical membrane throughout the
developing ureteric bud epithelium in early gestation
(arrowheads). u¼ ureteric bud. (d) CD24-IR was localized to
interstitial cells in the 36 week gestation fetal kidney (arrow),
whereas CD133 was localized predominantly to the developing
parietal and visceral epithelia of the glomerulus (arrowheads).
(e, f) In the postnatal kidneys CD24-IR was absent in the epithelia
of the nephron, but occasional CD24þ cells were again identified
in the interstitium (arrows). CD133-IR was localized to the visceral
and parietal epithelium of the developed glomerulus (g) and to
the proximal tubule (arrowheads). (g) CD24-IR was observed in
cells of the macula densa of the early distal tubule (arrow). (h)
Colocalization of CD24 and CD133-IR in the cells of macula densa
(arrow) and expression of CD133 in the visceral and parietal cells
of glomeruli (arrowheads). Bars: (a–g)¼ 25mm; (h)¼ 10 mm.
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was localized diffusely to the epithelia of both the proximal
and distal tubule, and to the parietal and visceral epithelia of
the developing glomerulus (Figures 2d–f).
In early gestation kidneys, CD133 immunoreactivity
localized to both the cytoplasm and the apical membrane.
In the later gestation kidneys (27 weeks) CD133 localized to
the apical membrane (Figure 2c). In addition, in mature
postnatal kidneys, CD133 colocalized with CD24 in a
punctate manner in the cells of the macula densa (Figure 2h).
Normal epithelial determination
To further study the relationship of CD24 to tubular
epithelial cell differentiation, we first highlighted the details
of E-cadherin and b-catenin immunoreactivity in the
nephrogenic zone (Figures 3a–c). Notably both E-cadherin
and b-catenin were absent in the undifferentiated metaneph-
ric mesenchyme. b-Catenin expression was first noted in the
initial epithelial aggregates at the tips of the branched ureteric
bud, indicating initial commitment of the metanephric
blastema cells to an epithelial phenotype (Figure 3a). With
cell polarization and development of the renal vesicle,
b-catenin expression increased and localized to the apical
membrane of the differentiating epithelial cell. At the stage of
glomerular vascularization, E-cadherin and b-catenin im-
munoreactivity colocalized (Figures 3b and c) distinctly to
the intercellular junctions of the developing tubular epithe-
lium. In the postnatal kidney b-catenin localized to the
proximal and distal tubule, whereas E-cadherin was absent
from the proximal tubule (Figure 3d). Throughout gestation
both E-cadherin and b-catenin colocalized to the intercellular
junctions of the cells of the developing ureteric bud.
We next sought to define the relationship between
induction of CD24 expression and early epithelial cell
determination. With early induction of the metanephric
mesenchyme, the earliest epithelial clusters and aggregates at
the tips of the ureteric buds expressed cytoplasmic b-catenin,
with minimal or no expression of CD24 at this stage (Figure
3e). With further development of this induced epithelium,
CD24 expression was initiated in the comma and S-shape
stages of differentiation (Figures 3e–g). As the S-shape
nephron differentiated further, CD24 expression was most
abundant in the cells coexpressing b-catenin, and destined to
become the tubular epithelium, as opposed to faint
expression in early committed podocytes, which also lacked
b-catenin expression (Figures 3f and g). Notably, abundance
of CD24 expression diminished with increasing gestational
age (Figure 4). At the end of nephrogenesis, b-catenin
expression was absent from the glomerular epithelia and was
restricted to the epithelia of the proximal and distal tubules,
whereas CD24 disappeared from the renal cortex (Figure 3h).
Association of CD24 and Ki-67
To further investigate the role of CD24 in renal epithelial
development, we studied the relationship of CD24 and Ki-67
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Figure 3 |Normal kidney epithelial determination. E-cadherin and b-catenin IR during normal kidney epithelial determination (a–d).
(a) In the 11 week gestation kidney, both E-cadherin-IR (red) and b-catenin-IR (green) were absent in the undifferentiated metanephric
mesenchyme (mm). b-Catenin-IR was first observed in the 11 week kidney in the initial epithelial aggregates (a) at the tips of the branched
ureteric bud (u). (b, c) In the 17 and 27 week gestation kidneys, respectively, b-catenin-IR becomes more abundant, and localizes to the
apical membrane of the differentiating epithelial cells of the renal vesicle (v). With vascularization of the glomerulus (g), the developing
proximal tubular epithelium (pt) shows distinct intercellular localization of both E-cadherin and b-catenin (yellow). (d) In the postnatal
kidney b-catenin-IR localizes to the proximal tubule (pt), whereas E-cadherin-IR is absent. Throughout gestation both E-cadherin and b-
catenin show distinct colocalization at the intercellular membranes of cells of the developing ureteric bud. b-Catenin and CD24-IR during
normal kidney epithelial determination (e–h). (e) In the 11-week kidney b-catenin IR (green) was localized to epithelial clusters and
aggregates (a) at the tips of the ureteric buds (u), with CD24-IR in the comma-shaped epithelial structures (c) (arrows). (f, g) In the 17 and
27 week gestation kidneys, CD24-IR (red) was localized in the comma (c) and S-shape (s) stages of epithelial differentiation. In the
developing S-shape nephron, CD24-IR expression was most abundant in the cells co-expressing b-catenin. CD24-IR decreased with
increasing gestational age (arrows). (h) In the postnatal kidney b-catenin-IR was restricted to proximal (pt) and distal tubules, while CD24-IR
completely disappeared from the renal cortex. Bars (a–h)¼ 25mm.
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expression, a cell proliferation marker. In early gestation
kidneys the markers coexpressed in the cells in the
nephrogenic zone, in particular in the cells of the induced
epithelial aggregates, developing vesicles, and comma and
S-shape bodies (Figure 5a).
A decrease in Ki-67 expression, which reflected reduced
cell proliferation, was observed in the lower segment of the S-
shape body (podocyte layer), in contrast to that in the middle
(proximal tubule) and upper (distal tubule) segments
(Figures 5a and b). At the capillary loop stage of develop-
ment, Ki-67 expression in the glomerulus was restricted to
occasional positive cells (Figures 5b and c). This loss of cell
proliferative activity was associated with reduction in the
expression of CD24 (Figure 4). At later gestational ages,
CD24 and Ki-67 expression was less abundant, restricted to
the developing renal vesicles in the thin nephrogenic zone.
Rare Ki-67þ cells were detected in the glomerulus and in the
surrounding interstitium (Figure 5c). In the postnatal kidney,
Ki-67 immunoreactivity was dramatically reduced and
restricted to rare cells of the tubular epithelium, mature
glomeruli, and interstitium (Figure 5d), which also expressed
CD24. These data show an association between CD24 and Ki-
67 expression in the developing kidney epithelium, suggest-
ing a role for CD24 in cellular proliferation.
FACS analysis of fetal kidney cells
Freshly dissociated fetal kidney (14–18 weeks gestation)
cortical cells were plated onto plastic tissue culture dishes
and allowed to adhere and proliferate for 48 h before
fluorescence-activated cell sorter (FACS) analysis and sorting.
By FACS analysis, using single and dual labeling for CD24
and CD133, four populations of cells were identified and
collected. In single-labeling analysis CD24þ cells constituted
up to 39% of the total cell population, whereas CD133þ cells
constituted 37% of the total (n¼ 3 kidneys). This was
confirmed with dual labeling, which showed four
distinct populations of cells: CD24þCD133 (16%),
CD24þCD133þ (13%), CD24CD133þ (2%), and
CD24CD133 (43%) (Figure 6a). All four cell populations
were plated on individual 96-well plates and then character-
ized by phase-contrast microscopy and immunoreactivity.
As expected, the results showed the integrity of the
isolation, with the CD24þCD133 cells expressing only
CD24 immunoreactivity (Figure 6b), the CD24þCD133þ
cells expressing both (Figure 6c), the CD24CD133þ cells
expressing only CD133 (Figure 6d), and the CD24CD133
cells negative for both.
Molecular characterization of isolated cell populations
Total RNA was extracted immediately from fresh fetal
kidneys, from unsorted kidney cells grown in primary culture
(bulk), and from sorted cells grown in primary culture. As
expected, the early fetal kidney and unsorted bulk primary
cells showed similar gene expression profiles, including the
genes of interest CD24 and CD133, genes of early kidney
precursors, OCT-4 and cadherin-11, and genes expressed
during early renal epithelial cell commitment and determina-
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Figure 4 |Quantification of CD24 and Ki-67 immunoreactivity.
CD24 and Ki-67 immunoreactivity was analyzed and measured in
the S-shape bodies and induced epithelial structures of the
nephrogenic zone of normal fetal kidneys between the
gestational ages 8 and 36 weeks (see Methods). Both CD24 and
Ki-67 immunoreactivity decreased significantly with advancing
gestational age. *Po0.05 versus 8 weeks, þPo0.05 versus 18
weeks. n¼ 5–29 measurements from three kidney fields at each
gestational age.
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Figure 5 |Association of CD24 and Ki-67 expression. (a) In
8 week gestation kidneys most cells of the developing epithelial
vesicles (v) and S-shape nephrons (s) express Ki-67-IR (green) and
CD24-IR (red) (arrows), with less abundant Ki-67 expression in the
ureteric duct (u) and in the metanephric mesenchyme (mm).
(b) Eighteen week gestation kidneys show coexpression of both
markers in the developing segments of the nephron (arrows), with
Ki-67-IR in cells of the ureteric bud (arrowhead) and in the
metanephric mesenchyme (mm). (c) CD24 and Ki-67 expression
was restricted to the thin nephrogenic zone of the 36 week
gestation kidney, in the induced epithelium of the developing
S-shape nephron(s) (arrow). (d) In postnatal kidneys rare Ki-67-
expressing cells were seen in the tubular epithelium, glomeruli,
and interstitium, and occasional CD24 and Ki-67 double-positive
cells (arrow) in the peritubular interstitium. Bars (a–d)¼ 25 mm.
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tion, including PAX2, Wnt-4, and SIX2. In the sorted cell
populations the CD24 and CD133 genotype confirmed their
phenotype. Notably, however, the CD24þ cells, and in
particular the CD24þCD133 population, expressed OCT-4,
Wnt-4, and SIX2 mRNA, indicative of a renal epithelial
precursor cell line (Figure 7).
Effects of fetal urinary tract obstruction
Obstructed fetal kidneys were studied at early and late
gestation, and postnatally. Obstructed 18 week gestation
kidneys showed incomplete metanephric differentiation and
failure of normal nephrogenesis. As in the normal kidneys of
comparable gestation, expression of CD24 was observed
mainly in the early-induced epithelial structures and devel-
oping tubules (Figure 8a). CD133 was expressed in the
parietal cells of dilated Bowman’s capsule and in the cyst
epithelia. E-cadherin expression was disrupted, with diffuse
expression throughout the cytoplasm of tubular epithelial
cells, but also colocalizing with b-catenin at the basolateral
membranes (data not shown).
The obstructed kidney at 36 weeks gestation showed
significant tubulointerstitial fibrosis, tubular dilatation, and
disruption of normal nephrogenesis. These changes were
associated with increased expression of both CD24 and
CD133 in the parietal glomerular epithelial cells and in the
epithelia of the dilated tubules (Figure 8b). CD24þ cells
were scattered in the interstitium, particularly around
dilated tubules. Abundant CD24 immunoreactivity was also
present along the apical surface of the thin cystic tubular
epithelium.
In the obstructed kidneys examined postnatally, epithelial
cells were observed in the dilated tubules and collecting
ducts, which expressed both CD24 and CD133 (Figure 8c).
CD24þ and CD24 and CD133 double-positive cells were
observed in the interstitium and around the severely dilated
tubules.
CD24 and CD133 mRNA expression in normal and obstructed
fetal kidneys
Total RNA extracted from whole kidneys and analyzed by
Affymetrix arrays identified a total of 6154 genes, which were
differentially expressed in 18 week gestation kidneys when
compared with that in 8 week gestation kidneys, and 5709
genes in obstructed kidneys as compared with normal
controls (Geo accession no. GSE18969). CD24 and CD133
were significantly increased in the obstructed fetal kidneys
(1.4- and 2.1-fold increases, respectively; Po0.01). The
relative expression of CD24 and CD133 mRNA in normal
and obstructed human fetal kidneys was confirmed by
quantitative real-time reverse transcription-PCR (RT-PCR).
In normal kidneys, both CD24 and CD133 mRNA expression
decreased with advancing gestational age as compared
to 8 weeks gestation kidneys (Figure 9a). Although there
were no differences between early obstructed kidneys and
normal controls, both CD24 and CD133 mRNA expression
was increased in late gestation obstructed kidneys when
compared with that in early gestation normal and obstructed
kidneys (Figure 9b).
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Figure 6 | Flow cytometry, cell isolation, and characterization.
(a) Single-cell suspensions from fetal kidneys were analyzed by
flow cytometry and sorted by dual labeling with CD24 and CD133
antibodies (see Methods). (b) CD24-IR (red) in CD24þCD133
cells. (c) CD24 and CD133-IR (green) in CD24þCD133 cells.
(d) CD133-IR in CD24CD133þ cells. Bar¼ 25 mm.
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Figure 7 |Molecular characterization of isolated cell
populations. RT-PCR analysis of the genes of interest, CD24 and
CD133, genes of early kidney precursors OCT-4 and cadherin-11,
and genes expressed during early renal epithelial cell
commitment, including PAX2, Wnt-4, and SIX2, using RNA
extracted from early gestation (14 week) human fetal kidneys
(HFK), from unsorted bulk primary cells (bulk) and from P0 of the
sorted CD24þ /CD133þ (þ /þ ), CD24þ /CD133 (CD24),
CD24/CD133þ (CD133), and CD24/CD133 (/) populations.
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DISCUSSION
We have identified and characterized the spatial and temporal
expression of CD24þ cells in the developing human fetal
kidney. CD24 is a cell-surface antigen expressed transiently in
early gestation in the nephrogenic zone of human fetal
kidneys, is downregulated during the second trimester of
gestation, but persists in select cells in the medullary
interstitium of the late gestation and postnatal kidney. In
the nephrogenic zone of the early gestation kidney, CD24 is
coexpressed with b-catenin in early epithelial aggregates that
are committed to differentiate into the tubular epithelia. This
epithelial expression persists to approximately 27 weeks
gestation and is not present in the differentiated tubular
epithelia. Interestingly CD24 expression is first noted in cells
undergoing mesenchymal–epithelial transition in the fetal
kidney. As described by others, early events in these early
committed cells include downregulation of the SIX2 gene,
necessary to maintain the renal progenitor population, and
upregulation of members of the Wnt family of transcription
factors, including Wnt-4. Upregulation of CD24 expression
appears to temporally follow these events, giving clues to its
role and regulation.
The role of CD24 in kidney development is currently
unclear. This human cell-surface antigen is a sialoglycopro-
tein anchored to the cell surface through a glycosyl
CD133
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Figure 8 | Effects of fetal urinary tract obstruction. (a) In
kidneys examined during early gestation and after urinary tract
obstruction, CD24 immunoreactivity (red) localized to the
disrupted nephrogenic zone and to the developing epithelial
structures of the nephron (arrows), with abundant and diffuse
cytoplasmic expression. CD133 immunoreactivity (green) was
abundant and localized to glomerular visceral and parietal cell
layers and to the cystic tubular epithelia (arrowheads). (b) In
obstructed kidneys examined during later gestation when
nephrogenesis was complete, CD24-IR was abundantly expressed
on the apical surface of obstructed tubular epithelia and was
found in scattered cells in the interstitium (arrows), whereas
prominent CD133-IR was found in the cytoplasm of epithelial cells
of dilated tubules (arrowheads). (c) In the obstructed kidneys
studied postnatally, CD24-IR localized to the nuclei of epithelial
cells of dilated tubules (arrows), in some instances colocalizing
with CD133-IR, whereas CD133-IR was faintly expressed in the
cytoplasm of tubular epithelial cells (arrowhead). Bars:
(a)¼ 50mm; (b)¼ 25mm; (c)¼ 10 mm.
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Figure 9 |CD24 and CD133 gene expression. The effects of
maturation and of obstruction on CD24 and CD133 mRNA
expression were compared using quantitative PCR analysis.
(a) CD24 and CD133 mRNA expression was decreased in normal
kidneys at 15 and 18 weeks gestation as compared with early
gestation kidneys at 8 weeks. (b) CD24 and CD133 mRNA
expression was increased in the obstructed 38 week gestation
kidneys when compared with that in the 18 week normal and
obstructed kidneys; n¼ 3 for normal 8 week, n¼ 3 for normal 15
week, n¼ 3 for normal 18 week, n¼ 2 for obstructed 18 week, and
n¼ 2 for obstructed 36 week kidneys.
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phosphatidylinositol linkage.8,9 CD24 is expressed on im-
mature cells and is usually absent from the cells that have
reached their final differentiation stage. Expression of CD24
is strongly induced and then repressed again during
maturation of T-cells and B-cells, in developing neurons,
and in regenerating muscle.10–16 It has been shown that CD24
is central to maintaining cancer cell growth and anchorage-
independent proliferation and survival.17 Furthermore, ex-
pression of CD24 has also been detected during development
in the intestinal mucosal epithelium, nasal epithelium, ductal
epithelium of salivary gland, bronchial epithelium, renal
tubular epithelium, and hair follicles.14 These observations
suggest that CD24 may be important in human embryonic
kidney epithelial cell differentiation, and therefore a poten-
tially useful marker of renal progenitor cells.
The regulation and biological effects of CD24 in the
developing kidney epithelial cell population are also unknown.
Temporal and spatial expression suggests upstream regulation by
Wnt signaling as has been described in breast cancer cells,18 and
likely through the effects of nuclear translocation of the ternary
complex factor (TCF) and b-catenin on CD24 gene transcrip-
tion. Once translated, the fate of the CD24 protein includes
shuttling to the cell membrane, where its function is modulated
through interaction with lipid rafts and b1-integrin.19,20 Cell-
surface CD24 is endocytosed to the cell cytoplasm through
multivesicular bodies and then either degraded through
incorporation into lysosomes or recycled to the cell membrane
and/or incorporated into exosomes.21,22 Nuclear translocation of
CD24 has been shown to upregulate the epithelial transcrip-
tome, in particular E-cadherin,23 and through inhibition of the
transcriptional effects of nuclear SMAD, downregulate fibro-
blast-specific gene transcription, key processes in embryonic
kidney mesenchymal-epithelial transition.
Most notably we have successfully isolated and characteri-
zed several potentially important cell populations from
developing human kidneys. Taking advantage of their cell-
surface properties, we have sorted CD24þ , CD133þ , and
CD24þCD133þ cell populations. By immunohistochemistry
and RT-PCR analysis all populations were shown to have
maintained their phenotype after sorting. Further characteri-
zation of the CD24þ clones by PCR analysis showing
OCT-4, Wnt-4, and SIX2 mRNA expression supports their
epithelial precursor identity.
We have previously shown significant tubular epithelial
phenotypic changes resulting from fetal urinary tract
obstruction in both the human and nonhuman primate.24
These changes have suggested an epithelial–mesenchymal
transformation, particularly in the obstructed medullary
collecting duct, resulting in a remodeling of the epithelial cell
populations, and contributing to the prominent interstitial
fibrosis. Interestingly, in this study, we have shown
upregulation of both CD24 and CD133 in obstructed fetal
kidneys, localized to the injured tubular epithelium.
Although speculative, just as CD24 may have an important
role in the commitment and transition of kidney mesench-
ymal cells to an epithelial phenotype, upregulation of CD24
may also represent an important regulatory step in the
transition of a differentiated epithelium to a mesenchymal
phenotype, as seen in this model of epithelial injury and in
specific forms of cancer.25
METHODS
Fetal tissue collection
Fetal human kidney tissue specimens were collected in accordance
with the Human Ethics Guidelines of the University of British
Columbia. Normal and obstructed kidney tissue was obtained from
elective abortions and autopsy, and surgical specimens from
gestational age 8 weeks to postnatal age 2 years. Obstructed kidneys
were collected at 18 weeks (n¼ 2), 36 weeks (n¼ 3), and postnatally
at 1–2 years (n¼ 2), while normal kidneys were collected from 8–18
weeks gestation (n¼ 5), 26–38 weeks gestation (n¼ 9), and
postnatal 1–5 years (n¼ 3).
Immunofluorescence histochemistry
Collected tissue was immediately fixed in 4% paraformaldehyde
with 0.2% glutaraldehyde, washed in 70mM phosphate-buffered
saline, 70% EtOH, and then embedded in paraffin. The tissue blocks
were then sectioned to 5-mm-thick sections. Tissue sections were
deparaffinized in xylene, dehydrated through graded ethanol
concentrations, exposed to 40min of heat-induced antigen retrieval
in pre-heated 10mM citrate buffer (pH 6.0), then incubated at room
temperature for 1 h in blocking buffer with 2% of either goat or
horse normal serum. Primary antibodies were added and incubated
overnight at 41C. The cells grown on glass coverslips were washed,
fixed with 4% paraformaldehyde for 15min, and permeabilized with
0.1% Triton X-100 for 10min. The primary antibodies included
mouse anti-E-cadherin (1:100; BD Transduction Laboratories,
Mississauga, ON, Canada), rabbit anti-CD133, mouse anti-CD24
(1:50; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-rabbit
b-catenin (1:100; Cell Signalling Technology, Danvers, MA, USA),
and anti Ki-67 (1:100). Sections were incubated for 1 h with
fluorescently conjugated secondary antibodies diluted in 0.1 M
phosphate-buffered saline containing 0.5% sodium azide. The
secondary antibodies used and their dilutions were goat anti-
rabbit-IgG Alexa-Fluor-488 conjugates or goat anti-mouse-IgG
Alexa-Fluor-568 conjugates (1:400 respectively; Invitrogen, Carlsbad,
CA, USA).
Quantification of Ki-67 and CD24 immunoreactivity
Quantification of Ki-67 and CD24 was performed using the Image-
Pro Plus version 6.2 software (Media Cybernetics, Silver Spring,
Bethesda, MD, USA). Fluorescent images were first extracted for
each channel at 8-bit depth (0–255 pixel intensity range). Back-
ground was eliminated by excluding gray scale (pixel intensity)
values lower than 40% of the maximum pixel intensity. For Ki-67
nuclear staining positive nuclei and total nuclei area were measured.
For CD24 the positively stained area and gray density area were
measured for a minimum of five S-shape bodies (n¼ 5–29
measurements) in three different kidney fields at each gestational
age. Mean staining was calculated on the basis of mean density and
mean area measurements.
Cell isolation and expansion
Fetal kidneys were collected under sterile conditions and minced
and digested for 45min with 2mg/ml collagenase type-IV (Sigma
Aldrich, Oakville, ON, Canada). The tissue suspension was rinsed
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through a 100-mm and then a 40-mm filter (Falcon, Franklin Lakes,
NJ, USA) and cells were collected by centrifugation at 1000 r.p.m. for
5min. Cell viability was determined by Trypan blue exclusion and
found to be 490% with all specimens. The cells were seeded onto
six-well culture plates at a density of 0.5–1.0 105 cells per well and
incubated in a 5% CO2 incubator at 371C in culture medium
including: Dulbecco’s modified Eagle’s medium/HAM F12, 50U/ml
penicillin, 50 mg/ml streptomycin (Gibco-BRL, Burlington, ON,
Canada), 10 mg/ml insulin (Sigma-Aldrich), 0.1mM non-essential
amino acids (Gibco-BRL), 2mM L-glutamine (Gibco-BRL), 1
insulin–transferrin–selenium (Gibco-BRL), and 5% fetal bovine
serum. The culture medium was changed every 2 days. Single-cell
suspensions were used for flow cytometry analysis and immuno-
fluorescence microscopy.
Isolation of RNA and reverse transcription quantitative
(RT) PCR
Fetal kidneys were collected in RNAlater (RNA stabilization reagent;
Qiagen, Mississauga, ON, Canada) or samples were stored at
p801C until isolation of RNA. The RNeasy Mini kit (Qiagen)
was used for RNA purification. cDNAwas prepared from 1mg of total
RNA using the iScript cDNA Synthesis kit (Bio-Rad, Mississauga, ON,
Canada) according to the manufacturer’s protocol. The PCR protocol
consisted of 35 cycles at 941C for 45 s, 58–621C for 45 s, depending on
the melting temperature of the primers, and 721C for 1min 30 s.
Table 1 includes a list of primers used for these experiments. A 578-bp
fragment of b-actin mRNA was also amplified by RT-PCR as the
internal control. The amplified products were size-fractionated by 2%
agarose gel electrophoresis. For relative quantification of CD24 and
CD133 genes by quantitative PCR analysis, the predesigned TaqMan
GEAs probes with a reporter dye (FAM) at the 50-end and a quencher
(MGBNFQ) at the 30-end were used (Hs02379687_s1; Hs01009259_m1;
ABI, Foster City, CA, USA). All samples were amplified in triplicate
using a 7000 Sequence Detection System using the TaqMan Universal
PCR Master Mix (ABI). Optimization and relative quantification of
the assay was performed as described in User’s Bulletin No. 2 (ABI).
Each primer and probe set was validated as per User’s Bulletin No. 2 to
ensure accurate results for relative quantification using the comparative
Ct method with fold change (2
DDC t). Normalization of RNA quantity
between samples was accounted for using the expression of the
housekeeping gene cyclophilin-A (Hs99999904_m1; ABI). The fold
difference of each gene between samples was then determined relative to
control kidneys.
DNA gene array
The gene expression microarray data were generated using the
Affymetrix HG-U133 Plus 2 chip using RNA extracted from freshly
collected fetal kidneys. There are 54,675 probe sets on each array.
Array analysis was performed using five kidney samples between 8
and 18 weeks gestation (normal n¼ 3, obstructed n¼ 2). Total RNA
(1.5 mg) was subjected to a standard eukaryotic target preparation
protocol as detailed in the GeneChip Expression Analysis Technical
Manual. In brief, double-stranded cDNA was synthesized using a
One-Cycle cDNA Synthesis kit (Affymetrix, Santa Clara, CA, USA).
The double-stranded cDNA was purified with a Sample Cleanup
Module (Affymetrix) and then subjected to in vitro transcription
(IVT) using an IVT Labeling kit (Affymetrix).
FACS analysis and cell sorting
Sorting was performed using cells in liquid suspension after
incubating with fluorescently tagged antibodies directed against
specific cell-surface proteins. The cells from fetal kidneys were
isolated as described above. The cells were filtered through cell
strainer caps (40 mm mesh) to obtain a single-cell suspension
(approximately 106 cells per ml for analysis, 1–2 107 cells per ml
for sorting). Surface antigens were labeled by incubating with the
primary antibodies anti-CD24 (clone 3H 1143; Santa Cruz
Biotechnology) and anti-CD133 (clone H-284; Santa Cruz Biotech-
nology) for 30min in the dark at 41C, followed by incubation for
30min with the appropriate Alexa-Fluor-488 goat anti-mouse or
Alexa-Fluor-647 goat anti-rabbit fluorescent secondary antibodies.
7-Amino-actinomycin-D (BD PharMingen, San Jose, CA, USA) was
added to the cells immediately before analysis to exclude the
7-amino-actinomycin-D-positive non-viable cell population. The
appropriate isotype-matched mouse monoclonal antibodies (Phar-
Mingen, San Diego, CA, USA), or secondary antibody alone, were
used as control to estimate the non-specific binding of target
primary antibodies and to assist in appropriate gate settings. The
stained cells were analyzed and sorted using the fluorescence-
activated cell sorter FACSAria (BD Biosciences, San Jose, CA, USA),
using the BD FACS DIVA software (BD Biosciences); data were
analyzed by collecting a minimum of 10,000 events and using
the FlowJo software (Tree Star, Ashland, OR, USA). Analysis of
the cells was accomplished using a FACS Calibur Flow Cytometry
System using the Cell Quest Pro software (BD Biosciences).
Four populations of cells were isolated for the analysis. These
included CD24þCD133þ , CD24CD133þ , CD24þCD133, and
CD24CD133.
Statistics
For analyses of differences in Ki-67 and CD24 expression between
various kidneys from different gestational ages, a two-sided
Student’s t-test was used, with a Po0.05 designated as a statistically
significant difference.
Table 1 | Primer sequences and product size (bp) for RT-PCR analyses
Gene Forward primer 50 to 30 Reverse primer 50 to 30 bp
b-Actin ATCTTGATCTTCATGGTGCTGGGC ACCACTGGCATTGTCATGGACTCT 545
Cad-11 GTTCTTGGCCCCAAGTTACA GTTCTTGGCCCCAAGTTACA 248
CD24 ACCCACGCAGATTTATTCCA GACGTTTCTTGGCCTGAGTC 243
CD133 TCAGGATTTTGCTGCTTGTG GCAGTATCTAGAGCGGTGGC 480
MAP-2 GGCATTGAAGAATGGCAGAT TCCTTGCAGACACCTCCTCT 291
Nestin CAGGAGAAACAGGGCCTACA TAAGAAAGGCTGGCACAGGT 313
OCT-4 AGTGAGAGGCAACCTGGAGA AGTGCAGTGAAGTGAGGGCT 279
PAX2 GAAAGGCTGCTGAACTTTGG TATGCACTGCAAAGCAGACC 436
SIX2 TCACAAGAATGAAAGCGTGC CGGGTTGTGGCTGTTAGAAT 472
Wnt-4 GCATCTCAGAGGAGGAGACG TCAGAGCATCCTGACCACTG 364
Abbreviation: RT-PCR, reverse transcription-PCR.
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Statistical analysis for gene microarray data was conducted using
the LMGene software for data transformation and identification of
differentially expressed genes in gene expression arrays, and data
were normalized using Affy/RMA. The new version 2.6.0 of R was
used for the analysis. To identify differentially expressed genes,
posterior-FDR P-value was computed for each probe set. P-values
less than 0.05 were considered significant.
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